Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 24:3:1405401.
doi: 10.3389/frabi.2024.1405401. eCollection 2024.

Prescriptive appropriateness of dalbavancin in acute bacterial skin and skin structure infections in adults: an integrated approach between clinical profile, patient- and health system-related factors and focus on environmental impact

Francesco Di Gennaro  1
Affiliations

Prescriptive appropriateness of dalbavancin in acute bacterial skin and skin structure infections in adults: an integrated approach between clinical profile, patient- and health system-related factors and focus on environmental impact

Francesco Di Gennaro. Front Antibiot. .
No abstract available

Keywords: ABSSSIs; MRSA; antibiotic therapy; clinical efficacy; dalbavancin; patient compliance; pharmacoeconomics.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Agenzia Nazionale per i Servizi Sanitari (2022) Il personale del Servizio Sanitario Nazionale. Available online at: https://www.agenas.gov.it/images/agenas/In%20primo%20piano/personale/per....
    1. Berniak-Woźny J., Rataj M. (2023). Towards green and sustainable healthcare: A literature review and research agenda for green leadership in the healthcare sector. Int. J. Environ. Res. Public Health 20, 908. doi: 10.3390/ijerph20020908 - DOI - PMC - PubMed
    1. Caselli D., Mariani M., Colomba C., Ferrecchi C., Cafagno C., Trotta D., et al. (2024). Real-world use of dalbavancin for treatment of soft tissue and bone infection in children: safe, effective and hospital-time sparing. Children (Basel). 11, 78. doi: 10.3390/children11010078 - DOI - PMC - PubMed
    1. Dunne M. W., Talbot G. H., Boucher H. W., Wilcox M., Puttagunta S. (2016). Safety of dalbavancin in the treatment of skin and skin structure infections: A pooled analysis of randomized, comparative studies. Drug Saf. 39, 147–157. doi: 10.1007/s40264-015-0374-9 - DOI - PMC - PubMed
    1. Eii M. N., Walpole S., Aldridge C. (2023). Sustainable practice: Prescribing oral over intravenous medications. BMJ. 383, e075297. doi: 10.1136/bmj-2023-075297 - DOI - PubMed

LinkOut - more resources